ScreenerHero

NOLA-B Nolato AB (publ)

STO · SE · Healthcare · Medical Devices · nolato.com
55.40SEK-0.18%Mkt Cap: 1.43B $P/E: 20.83

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Sol…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc. - Common Stock
$32.21BUSDP/E 33.7
GEHC
GE HealthCare Technologies Inc. - Common Stock
$29.24BUSDP/E 14.8
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
TXG
10x Genomics, Inc. - Common Stock
$12.18BUSD
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
GKOS
Glaukos Corporation
$9.67BUSD

Key Statistics

Company
Market Cap1.43B USD
Enterprise Value1.55B USD
Revenue (TTM)901.52M USD
Gross Profit165.48M USD
Net Income (TTM)74.32M USD
Revenue/Share34.99 SEK
Last Price55.40 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5.7K
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)20.83
P/E (Forward)18.94
PEG3.79
EV/EBITDA10.79
EV/Revenue1.72
P/S1.59
P/B2.63
EPS (TTM)2.66
EPS (Forward)2.93
52W Range
44.8053% of range64.65
52W High64.65 SEK
52W Low44.80 SEK
Profitability
Gross Margin18.28%
Oper. Margin9.66%
EBITDA Margin15.96%
Profit Margin8.21%
ROE14.05%
ROA8.37%
Growth
Revenue Growth2.50%
Earnings Growth-20.30%
Cash Flow & Leverage
Operating CF101.58M USD
CapEx (TTM)75.47M USD
FCF Margin1.77%
FCF Yield1.12%
Net Debt122.43M USD
Net Debt/EBITDA0.85
Balance Sheet
Debt/Equity0.26
Current Ratio1.56
Quick Ratio0.87
Book Value/Sh21.07 SEK
Cash/Share1.79 SEK
Dividends
Fwd Div Rate1.70 SEK
Trail. Div Rate1.70 SEK
Div. Yield3.06%
5Y Avg Yield2.82%
Payout Ratio63.91%
Ex-Div DateMay 7, 2026
Pay Date—
Splits
Last Split10:1
Split DateMay 12, 2021
Analyst Consensus
Rating—
Target (Mean)61.00 SEK
Upside (mean)+10.1%
Target Range60.00 SEK – 62.00 SEK
60.00+10.1% to mean62.00
# Analysts2
Ownership
Shares Out.241.79M
Float149.53M
Insiders20.47%
Institutions57.76%
Technical
SMA 5051.83 (+6.9%)
SMA 20051.80 (+6.9%)
Beta0.75
S&P 52W Chg14.58%
Avg Vol (30d)175.73K
Avg Vol (10d)186.48K
Technical Indicators
RSI (14)68.4
MACD0.7496
MACD Signal0.6824
MACD Hist.+0.0672
BB Upper55.07 SEK
BB Middle53.41 SEK
BB Lower51.75 SEK
BB Width6.22%
ATR (14)1.159 SEK
Vol Ratio (20d)1.23x